Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1729)
BIOMARIN PHARMACEUTICAL INC (BMRN)
Davis George Eric — EVP, Chief Legal Officer
Shares
17,557
Price
$66.28
Total Value
$1.16M
Shares Held After
61,003
% of Holdings
22.3%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
27,000
Price
$9.47
Total Value
$255.74K
Shares Held After
827,000
% of Holdings
3.3%
Beta Bionics, Inc. (BBNX)
Saint Sean — Director
Shares
16,867
Price
$19.11
Total Value
$322.38K
Shares Held After
404,070
% of Holdings
4.0%
Beta Bionics, Inc. (BBNX)
Feider Stephen — Chief Financial Officer
Shares
6,675
Price
$19.11
Total Value
$127.58K
Shares Held After
159,378
% of Holdings
4.0%
Beta Bionics, Inc. (BBNX)
Mensinger Mike — Chief Product Officer
Shares
4,375
Price
$19.11
Total Value
$83.62K
Shares Held After
180,040
% of Holdings
2.4%
Beta Bionics, Inc. (BBNX)
Hopman Mark — Chief Commercial Officer
Shares
5,327
Price
$19.11
Total Value
$101.82K
Shares Held After
124,027
% of Holdings
4.1%
Beta Bionics, Inc. (BBNX)
Russell Steven Jon — Chief Medical Officer
Shares
4,221
Price
$19.11
Total Value
$80.68K
Shares Held After
169,628
% of Holdings
2.4%
Tenon Medical, Inc. (TNON)
HRT FINANCIAL LP — 10% Owner
Shares
450
Price
$4.53
Total Value
$2.04K
Shares Held After
1,794
% of Holdings
20.1%
Tarsus Pharmaceuticals, Inc. (TARS)
Azamian Bobak R. — Director
Shares
10,000
Price
$80.06
Total Value
$800.60K
Shares Held After
837,991
% of Holdings
1.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$510.05
Total Value
$81.61K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$508.36
Total Value
$40.67K
Shares Held After
324,603
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$506.27
Total Value
$20.25K
Shares Held After
324,683
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$505.20
Total Value
$20.21K
Shares Held After
324,723
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$504.15
Total Value
$100.83K
Shares Held After
324,763
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$502.01
Total Value
$60.24K
Shares Held After
324,963
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$501.06
Total Value
$80.17K
Shares Held After
325,083
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
54
Price
$500.22
Total Value
$27.01K
Shares Held After
325,243
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
542
Price
$498.97
Total Value
$270.44K
Shares Held After
325,297
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
364
Price
$498.21
Total Value
$181.35K
Shares Held After
325,839
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
777
Price
$496.95
Total Value
$386.13K
Shares Held After
326,203
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
423
Price
$495.95
Total Value
$209.79K
Shares Held After
326,980
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$494.33
Total Value
$257.05K
Shares Held After
327,403
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
520
Price
$493.59
Total Value
$256.67K
Shares Held After
327,923
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,067
Price
$492.25
Total Value
$1.02M
Shares Held After
328,443
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,833
Price
$491.38
Total Value
$900.70K
Shares Held After
330,510
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$490.19
Total Value
$274.51K
Shares Held After
332,343
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$489.06
Total Value
$117.37K
Shares Held After
332,903
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$486.32
Total Value
$77.81K
Shares Held After
333,143
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$485.12
Total Value
$58.21K
Shares Held After
333,303
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
80
Price
$482.61
Total Value
$38.61K
Shares Held After
333,423
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$479.89
Total Value
$76.78K
Shares Held After
333,503
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$478.85
Total Value
$76.62K
Shares Held After
333,663
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$477.70
Total Value
$57.32K
Shares Held After
333,823
% of Holdings
0.0%
Hims&Hers Health, Inc. (HIMS)
Boughton Soleil — Chief Legal Officer
Shares
3,458
Price
$28.33
Total Value
$97.97K
Shares Held After
310,506
% of Holdings
1.1%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
900
Price
$68.95
Total Value
$62.05K
Shares Held After
526,900
% of Holdings
0.2%
Teladoc Health, Inc. (TDOC)
DIVITA CHARLES III — Director
Shares
18,327
Price
$6.30
Total Value
$115.48K
Shares Held After
440,538
% of Holdings
4.0%
Teladoc Health, Inc. (TDOC)
Vandervoort Adam C — CHIEF LEGAL OFFICER, SECRETARY
Shares
7,573
Price
$6.30
Total Value
$47.72K
Shares Held After
117,616
% of Holdings
6.0%
Teladoc Health, Inc. (TDOC)
Catapano Joseph Ronald — Chief Accounting Officer
Shares
274
Price
$6.30
Total Value
$1.73K
Shares Held After
12,865
% of Holdings
2.1%
Teladoc Health, Inc. (TDOC)
Bliss Kelly — President, U.S. Group Health
Shares
7,357
Price
$6.30
Total Value
$46.36K
Shares Held After
92,832
% of Holdings
7.3%
Teladoc Health, Inc. (TDOC)
Nueno Carlos — President, International
Shares
6,200
Price
$6.30
Total Value
$39.07K
Shares Held After
64,744
% of Holdings
8.7%
Travere Therapeutics, Inc. (TVTX)
Cline Christopher R. — CHIEF FINANCIAL OFFICER
Shares
642
Price
$66.37
Total Value
$42.61K
Shares Held After
118,016
% of Holdings
0.5%
APTARGROUP, INC. (ATR)
Vinczeller Shiela — Chief Human Resources Officer
Shares
765
Price
$130.37
Total Value
$99.73K
Shares Held After
26,313
% of Holdings
2.8%
RxSight, Inc. (RXST)
Weinberg Eric — Chief Business Development Officer
Shares
2,041
Price
$6.96
Total Value
$14.21K
Shares Held After
200,348
% of Holdings
1.0%
RxSight, Inc. (RXST)
Kurtz Ronald M MD — Chief Medical Officer
Shares
5,100
Price
$6.96
Total Value
$35.50K
Shares Held After
71,775
% of Holdings
6.6%
RxSight, Inc. (RXST)
Goldshleger Ilya — Chief Operating Officer
Shares
2,041
Price
$6.96
Total Value
$14.21K
Shares Held After
81,509
% of Holdings
2.4%
RxSight, Inc. (RXST)
Wilterding Mark — Chief Financial Officer
Shares
7,765
Price
$6.96
Total Value
$54.04K
Shares Held After
25,049
% of Holdings
23.7%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
400
Price
$26.64
Total Value
$10.65K
Shares Held After
9,110
% of Holdings
4.2%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
5,387
Price
$25.69
Total Value
$138.42K
Shares Held After
9,510
% of Holdings
36.2%
TENAX THERAPEUTICS, INC. (TENX)
ADAR1 Capital Management, LLC — 10% Owner
Shares
187,704
Price
$1.80
Total Value
$337.59K
Shares Held After
5,624,151
% of Holdings
3.3%
Shares
3,000
Price
$0.05
Total Value
$146.70
Shares Held After
9,387,256
% of Holdings
0.0%
Showing 1–50 of 1729 transactions (page 1 of 35)